Characterization of the Sequence Specificity Determinants Required for Processing and Control of Sex Pheromone by the Intramembrane Protease Eep and the Plasmid-Encoded Protein PrgY by Chandler, Josephine R. & Dunny, Gary M.
JOURNAL OF BACTERIOLOGY, Feb. 2008, p. 1172–1183 Vol. 190, No. 4
0021-9193/08/$08.000 doi:10.1128/JB.01327-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Characterization of the Sequence Specificity Determinants Required for
Processing and Control of Sex Pheromone by the Intramembrane
Protease Eep and the Plasmid-Encoded Protein PrgY
Josephine R. Chandler† and Gary M. Dunny*
Department of Microbiology, University of Minnesota, MMC 196, 420 Delaware Street SE, Minneapolis, Minnesota 55455
Received 15 August 2007/Accepted 27 November 2007
Conjugative transfer of the Enterococcus faecalis plasmid pCF10 is induced by the peptide pheromone cCF10
when recipient-produced cCF10 is detected by donors. cCF10 is produced by proteolytic processing of the signal
sequence of a chromosomally encoded lipoprotein (CcfA). In donors, endogenously produced cCF10 is carefully
controlled to prevent constitutive expression of conjugation functions, an energetically wasteful process, except
in vivo, where endogenous cCF10 induces a conjugation-linked virulence factor. Endogenous cCF10 is con-
trolled by two plasmid-encoded products; a membrane protein PrgY reduces pheromone levels in donors, and
a secreted inhibitor peptide iCF10 inhibits the residual endogenous pheromone that escapes PrgY control. In
this study we genetically determined the amino acid specificity determinants within PrgY, cCF10, and the
cCF10 precursor that are necessary for cCF10 processing and for PrgY-mediated control. We showed that
amino acid residues 125 to 241 of PrgY are required for specific recognition of cCF10 and that PrgY recognizes
determinants within the heptapeptide cCF10 sequence, supporting a direct interaction between PrgY and
mature cCF10. In addition, we found that a regulated intramembrane proteolysis (RIP) family pheromone
precursor-processing protein Eep recognizes amino acids N-terminal to cCF10 in the signal sequence of CcfA.
These results support a model where Eep directly targets pheromone precursors for RIP and PrgY interacts
directly with the mature cCF10 peptide during processing. Despite evidence that both PrgY and Eep associate
with cCF10 in or near the membrane, results presented here indicate that these two proteins function
independently.
The gram-positive bacterium Enterococcus faecalis possesses
mobile genetic elements that can rapidly spread antibiotic re-
sistance and virulence determinants throughout bacterial pop-
ulations (16, 41). A well-studied example of this is the phero-
mone-inducible family of conjugative plasmids that can be
transferred to recipient cells at high rates upon induction by a
recipient-produced oligopeptide pheromone signal (21). In
this type of cell-cell signaling, communication occurs between
two distinct cell types: donors (plasmid-harboring signal detec-
tors) and recipients (plasmid-free signal producers). This is
distinct from classic quorum sensing in which a homogeneous
cell population serves as both the signal producer and the
signal detector. In E. faecalis pheromone-inducible conjuga-
tion, donor-recipient communication allows donors to activate
plasmid transfer only when recipient cells are in sufficiently
close proximity for conjugation, thus minimizing the metabolic
burden of the plasmid on its host cell.
The pheromone-inducible plasmids of E. faecalis have
evolved a highly specific and sensitive response to peptide
pheromones. These pheromones are small (7 to 8 amino ac-
ids), chromosomally encoded, and signal specifically to their
cognate plasmid or family of closely related plasmids (20).
Because donors produce pheromone, the plasmids have also
evolved mechanisms of pheromone control that bypass a po-
tential response to their own host cell’s endogenously pro-
duced pheromone (11). The best-studied representatives of the
pheromone-inducible plasmids are pCF10, pAD1, pPD1, and
the genetically less-related plasmid pAM373.
The steps of pheromone detection and response for pCF10
are outlined in Fig. 1A. The pCF10-specific pheromone cCF10
is bound at the cell surface by the pCF10-encoded PrgZ pro-
tein. After binding, cCF10 is imported into the cytoplasm via a
chromosomally encoded oligopeptide permease ABC trans-
porter (39). Inside the cytoplasm pheromone binds and desta-
bilizes tetramers of a plasmid-encoded intracellular regulator
PrgX (35, 47). This relieves PrgX-dependent repression of the
prgQ promoter (PQ) in pCF10 and ultimately drives the ex-
pression of downstream conjugation functions (6). The up-
stream sequence of prgQ contains two weak binding sites for
PrgX dimers, one of which overlaps PQ (5, 35). Protein-protein
interactions between pairs of PrgX dimers occupying the bind-
ing sites results in the formation of a DNA loop, which favors
cooperative binding of PrgX to both sites (35, 47). PrgX tet-
ramer destabilization by cCF10 disrupts the DNA loop and
thus abolishes PrgX-mediated repression at PQ (5). This ulti-
mately results in expression of a large number of genes in-
volved in conjugation (4, 6, 27, 35). One of these genes encodes
a surface-expressed protein, Aggregation Substance (Asc10),
which is involved in the formation of mating aggregates in
broth culture (32). Asc10 also enhances E. faecalis virulence
(40) and is induced in the absence of recipient cells in the
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mammalian bloodstream (28) by donor-produced pheromone
that escapes plasmid control (13). While the genetic determi-
nants for pheromone production and control have been iden-
tified, the molecular details of these processes are not com-
pletely understood.
pCF10 encodes two elements that control self-pheromone in
donor cells; a membrane protein PrgY and an inhibitor peptide
iCF10. PrgY reduces pheromone activity in both cell culture
supernatants and cell wall fractions of donor cells (9), possibly
by binding or degrading endogenous cCF10 as it is released
from the donor cell. However, PrgY does not encode any
known proteolytic or peptide interaction motifs and the possi-
bility that PrgY interacts directly with cCF10 has not yet been
explored. iCF10 is similar to cCF10 in size and hydrophobicity
and competes with cCF10 for intracellular PrgX binding (36).
Although iCF10 and cCF10 bind the same pocket of PrgX,
they have different effects; iCF10 binding enhances PrgX tet-
ramer formation and repression at PQ (36), whereas cCF10
binding has the opposite effect, as described above. The bal-
ance of iCF10 and cCF10 is carefully regulated so that iCF10
is produced at a level just sufficient to neutralize cCF10 in a
donor cell (13). It is thought that iCF10 neutralizes cCF10 that
escapes control by PrgY.
All pheromones analyzed to date appear to be encoded
within the N-terminal signal sequences of predicted surface
lipoproteins (17), and the inhibitor peptides are similarly en-
coded within signal sequence-like elements on the plasmid. All
of the pheromone precursors have a cysteine residue down-
stream of the pheromone sequence that is within a known
lipoprotein signal peptidase processing site (17). This cysteine
residue is the site where signal peptidase II cleaves, liberating
the signal peptide from the lipoprotein (18). In the case of the
putative lipoprotein CcfA, whose signal peptide contains the
mature cCF10 amino acid sequence, the cysteine residue is
three amino acids downstream from the C terminus of the
mature peptide and therefore may require further processing
by a host exoprotease. The current working model for post-
translational processing of cCF10 is illustrated in Fig. 1B.
A putative membrane protease Eep has been shown to be
involved in production of the cCF10, cAD1, and cPD1 phero-
mones (2). Eep is predicted to liberate the pheromone pep-
tides from their cognate lipoprotein signal sequences by endo-
proteolytic cleavage (2). Eep is a predicted metalloprotease
belonging to the site-2 protease (S2P) family of intramem-
brane-cleaving proteases (I-Clips) that cleave their substrate
by regulated intramembrane proteolysis (RIP) (7). Because
Eep appears to be a membrane protein, Eep-mediated cleav-
age of pheromone precursors is predicted to occur there and is
possibly accompanied by active export of pheromone across
the membrane to the extracytoplasmic environment. The
prepeptides of pheromones cOB1 and cAM373 do not appear
to be processed by Eep (2), implying the existence of an alter-
native processing system.
In this report, we describe the results of experiments that
address cCF10 production and control in donor cells. We con-
firm and extend previous studies showing that iCF10 can neu-
FIG. 1. (A) Model of pheromone response and control in a donor cell. cCF10 is imported into the cytoplasm, where it interacts with PrgX,
causing derepression of PQ and subsequent induction of downstream conjugation genes. PrgY reduces endogenous cCF10, and iCF10 neutralizes
remaining cCF10. (B) Predicted proteolytic processing of cCF10. cCF10 is processed from CcfA in several steps. SPII, signal peptidase II; Eep,
membrane protease; C.P., carboxy peptidase. Triangles indicate cleavage sites.
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tralize endogenous cCF10 but is insufficient to completely con-
trol self-induction in donors. We genetically characterize a
cCF10 specificity domain between amino acids 125 and 241 of
PrgY, providing evidence for cCF10 interaction through this
domain. We demonstrate that the amino acid sequence spec-
ificity determinants for PrgY recognition lie within the mature
cCF10 peptide, whereas those involved in Eep recognition are
located in the amino-terminal region of the signal peptide that
comprises the cCF10 precursor. We also report that PrgY acts
independently of Eep.
MATERIALS AND METHODS
Culture conditions. E. faecalis was grown at 37°C in Todd-Hewitt broth (THB;
Difco) or in M9-YE glucose medium (22), an M9-based medium supplemented
with 0.3% yeast extract, 1% Casamino Acids, 0.1% glucose, 1 mM MgSO4, and
0.1 mM CaCl2. Antibiotics were used at the following concentrations: tetracy-
cline at 10 g/ml, erythromycin at 10 g/ml, chloramphenicol at 20 g/ml,
rifampin at 200 g/ml, spectinomycin at 1,000 g/ml, kanamycin at 1,000 g/ml,
and fusidic acid at 25 g/ml. For growth of strains overexpressing pheromone or
inhibitor from the pDL278-derived vectors, antibiotics were used at 1/10 the
above concentrations. Nisin (Sigma) was used at 25 ng/ml in broth. Synthetic
iCF10 and cCF10 (Mimotopes, Australia) were dissolved at 50 g of dimethyl
formamide/ml and used at the indicated concentrations. Escherichia coli DH5
was used for cloning purposes and was grown in Luria-Bertani broth at 37°C with
antibiotics at the following concentrations: erythromycin at 200 g/ml, chloram-
phenicol at 20 g/ml, carbenicillin at 50 g/ml, kanamycin at 50 g/ml, and
spectinomycin at 50 g/ml.
Bacterial strains. Strains JRC107 and JRC110 were made by allelic exchange
using conjugative delivery according to the method of Kristich et al. (37). Mo-
bilizable and counterselectable donor plasmids were constructed for introducing
gene deletions (in the case of eep, sprE, and gelE) or point mutations introducing
stop codons (in the case of ccfA) into E. faecalis strain OG1RF. These donor
plasmids were made from the pORI280-derived mobilizable vector carrying the
counterselectable marker pheS* (33) and were transformed via electroporation
into the donor strain CK111(pCF10-101) (37). Subsequently, the donor plasmid
was transferred into strain OG1RF via conjugation and plated on selective
medium to select for transconjugants harboring chromosomally integrated copies
of the donor plasmid. These single-crossover strains were grown for approxi-
mately 20 generations at 37°C and plated on para-chlorophenyalanine to select
for excision of the integrated plasmid. Colonies that grew in the presence of
para-chlorophenyalanine were checked to verify that they did not acquire donor
chromosomal DNA conferring resistance to 5-fluorouracil (encoded by upp) or
to streptomycin and that they remained sensitive to the antibiotics fusidic acid
and rifampin (Table 1). After marker verification, potential recombinant strains
were screened for each strain-specific allele by phenotypic or PCR-based assays
as described previously (37).
DNA manipulation. Plasmids were isolated with a Qiagen miniprep kit as
recommended by the manufacturer. Digested DNA products were purified by us-
ing a Qiaquick gel extraction kit (Qiagen), and PCR products were purified using
a Qiaquick PCR purification kit (Qiagen). Plasmid constructs were verified using
restriction enzyme digestion. Restriction enzymes were purchased from Promega
and New England Biolabs. PCR was performed with a Perkin-Elmer Gene Amp
PCR system or an Eppendorf Mastercycler using either BioXact DNA polymer-
ase (Bioline), Platinum Pfx polymerase (Invitrogen), or Platinum Taq polymer-
ase (Invitrogen). All sequencing was done by the Advanced Genetic Analysis
Center at the University of Minnesota. Primers were purchased from Integrated
DNA Technologies, Inc. E. faecalis was transformed with DNA as described
previously (5). For all plasmids constructed using a PCR-generated fragment, the
DNA was sequenced to confirm that no mutation was incorporated by PCR.
Plasmids. The plasmids used in the present study are listed in Table 2. Plas-
mids pPCR4 and pJRC2, -3, and -4 were constructed using the gram-positive
shuttle vector pDL278 (23). pJRC2, -3, and -4 were constructed from pPCR4
(45). pJRC2 and pJRC3 were made by overlap extension PCR essentially as
described by Horton et al. (29). Upstream and downstream amplicons with
overlapping termini were separately amplified by PCR and then combined in
equimolar proportions and used as a template for overlap extension PCR, which
spliced them together. The upstream amplicon for both pJRC2 and pJRC3 was
amplified from plasmid pPCR4 (45) and spanned the prgQ promoter and up-
stream multicloning site in pPCR4. The downstream amplicon was amplified
from chromosomal E. faecalis DNA and spanned the signal sequence encoding
the pheromone cAM373 in the camE gene (25). For pJRC3, the 3 primer for the
downstream amplicon included base changes in the coding sequence for cAM373
pheromone so that this region instead encoded cCF10. These upstream and
downstream amplicons were used as a template for overlap extension PCR, and
the resulting PCR-amplified product was cloned into pGEM-T-Easy (Promega,
Madison, WI) to make pGEM pJRC2 or pGEM pJRC3. pJRC2 and pJRC3 were
constructed by excising the 250-bp fragments from pGEM pJRC2 or pGEM
pJRC3 with EcoRI and cloning them into EcoRI digested pDL278. Both frag-
ments contained an EcoRI site internal to the cloned piece at the 5 end and an
EcoRI site 10 bases external to the cloned piece at the 3 end within pGEM-T-
Easy. The resulting pJRC2 and pJRC3 constructs were screened for the same
insert orientation as that of pPCR4. For pJRC3, none were found of the 12 that
were screened, and a clone was picked that has the opposite insert orientation
from pPCR4 and pJRC2 in the multicloning site of pDL278. Because expression
of the cAM373 pheromone in pJRC2 is driven by the adjacent prgQ promoter
and not a vector-supplied promoter, we believe the orientation of the insert has
no effect on expression levels of the cAM373 pheromone. Plasmid pJRC4,
bearing modification in the cCF10 coding region of pPCR4 that resulted in
iCF10 expression, was constructed by using the QuikChange mutagenesis strat-
egy (Stratagene) with pPCR4 as the template. The nucleotide sequence of the
prgQ promoter and peptide coding sequence of the resulting pJRC4 plasmid was
determined to verify the desired changes to the cCF10 coding region.
Plasmids pMSP6043, pMSP6049, pMSP6043-1, and pMSP6043-2 were con-
structed by using the gram-positive shuttle vector pDL276 (23). pMSP6043
encodes the pCF10 region including prgN, -O, -P, -W, -Z, and -Y (26). pMSP6049
encodes the same region but has a spectinomycin resistance cassette cloned into
the middle of prgZ, resulting in abolished PrgZ expression (26). Plasmids
pMSP6043-1 encoding prgN, -O, -P, -W, and -Z (12) and pMSP6043-2 encoding
prgN, -O, -P, and -W were derived from pMSP6043. pMSP6043-2 was made by
ligating the EcoRI and PstI fragment from prgN through the middle of prgZ from
pINY6023 (46) into the EcoRI and PstI sites of pDL276 (23) and is in the same
orientation as pMSP6043-1. pMSP6043-1 and pMSP6043-2 were checked by
restriction digestion and Western blotting and found to express PrgZ but no
detectable PrgY (in the case of pMSP6043-1) and neither PrgZ nor PrgY (in the
case of pMSP6043-2) (data not shown).
Plasmids pMSP3545Y, pMSP3545S, and pMSP3545S-1 and -2, and pB/Y1-10
were made from pMSP3545, a nisin-inducible expression vector (8). pMSP3545S,
pMSP3545S-1, and pMSP3545S-2 were constructed as described previously (12),
pMSP3545Y was constructed by cloning PCR-amplified prgY into the XbaI/NcoI
sites of pMSP3545, and pB/Y1 to pB/Y10 were constructed using overlap exten-
sion PCR essentially as described by Horton et al. (29) (Table 2). For pB/Y1 to
pB/Y10, the coding sequences for the desired portions of pPD1 traB and pCF10
prgY were each PCR amplified using primer pairs that resulted in products with
overlapping termini. These PCR products were combined in equimolar propor-
tions and used as a template for overlap extension PCR to splice them together.
For overlap extension PCR, five cycles were done without primers to allow the
overlapping termini to anneal for extension of the recessed termini via Pfx
polymerase. After five cycles, primers corresponding to the DNA sequence of the
5 and 3 ends of the desired chimeric gene product with flanking NcoI/XbaI sites
TABLE 1. Strains used in this study
Strain Relevant characteristic or descriptiona Source orreference
E. coli DH5 E. coli cloning host Invitrogen
E. faecalis




CK111 Spectr 5-FUr; OG1Sp
upp4::P23repA4
37
TX5128 GelE SprE; m gelE insertion
in OG1RF
48
JRC107 cCF10-, GelE-, and SprE-deficient
OG1RF derivative
37
JRC110 Eep-deficient JRC107 derivative 37
a Rifr, rifampin resistance; Far, fusidic acid resistance; Spectr, spectinomycin
resistance; 5-FUr, 5-fluorouracil resistance.
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were added, and the PCR was continued for an additional 35 cycles. The result-
ing amplified chimeric PCR product was subsequently purified, digested with
NcoI/XbaI, and ligated into pMSP3545S cut with the same restriction enzymes.
Determination of pheromone activity in cell culture supernatants. Cell culture
supernatants were prepared for pheromone activity assays by first growing strains
overnight at 37°C without shaking in THB with appropriate antibiotics and 25 ng
of nisin/ml. Overnight cultures were immediately harvested (for strains overex-
pressing pheromone from the pDL278-derived plasmids) or diluted 1:5 or 1:10 in
fresh THB plus 25 ng of nisin/ml and grown an additional 4 to 6 h before
harvesting (for strains expressing pheromone from its native promoter). The
optical density at 600 nm was determined for each sample, and equivalent cell
volumes were harvested by centrifugation at 8,000 rpm (Beckman J2-21 centri-
fuge; JA20 rotor) for 10 min. For measuring pheromone from native promoters,
the supernatant from each sample was autoclaved for 15 min at 121°C and 15
lb/in2. Prepared supernatants were either immediately assayed for pheromone
activity or kept at 4°C for no more than 24 h before the pheromone activity was
measured.
The pheromone activity from cell culture supernatants was determined one of
two ways. High levels of pheromone activity produced from plasmids pJRC3 or
pPCR4 were determined by 	-galactosidase assay using OG1RF(p043lacZ) as an
indicator strain. Cell culture supernatants of overnight cultures grown in THB
plus 25 ng of nisin/ml was added to exponentially growing OG1RF(p043lacZ)
indicator cultures in M9-YE medium and incubated for 1.5 h before the 	-ga-
lactosidase activity was determined. Cell culture supernatants were added to
indicator cultures at a 1:100 dilution (for three cCF10 variants with low activity
[V2L, L4V and F6Y]), at a 1:400 dilution (for strains harboring pJRC3), or at a
1:200 dilution (for all other strains). All other cell culture supernatants were
subjected to a clumping assay (9) to detect pheromone activity. Briefly, twofold
serial dilutions of prepared supernatant samples were made in M9-YE medium
in a round-bottom-well microtiter plate. A total of 10 l of a 15-h
OG1RF(pCF10) indicator culture was added to each well. Samples were incu-
bated shaking at 37°C for 2 h, and positive clumping reactions were scored. The
titer is reported as the reciprocal of the highest dilution that demonstrated a
positive clumping reaction. The results reported are representative of at least two
independent experiments done on separate days.
Determination of inhibitor activity in cell culture supernatants. To determine
inhibitor activity, cell culture supernatants were prepared as for determination of
pheromone activity. Inhibitor assays were done as described previously (30) with
some modifications. A known concentration of synthetic cCF10 (50 ng/ml) was
serially diluted (1:2) through 100-l aliquots of the culture filtrate being tested
for inhibitor activity, and 10 l of responder cells was added to each well before
incubation at 37°C with shaking. The inhibitor activity was measured as the
extent of the reduction of the pheromone titer relative to a parallel control when
broth was substituted for culture filtrates. The inhibitor titer was therefore
TABLE 2. Plasmids used in this study
Plasmid Relevant characteristic or descriptionc Source orreference
pCF10 cCF10-inducible conjugative plasmid 19
pCF10-101 pCF10 
oriT2 49
pPD1 cPD1-inducible conjugative plasmid 52
pBK2 pCI3340 vector containing prgX-Q region of pCF10 with a pheromone-
inducible lacZ reporter gene
34
p043lacZ pAT18 vector containing prgX-Q region of pCF10 with a pheromone-
inducible lacZ reporter gene
35
pDL278 Gram-positive cloning shuttle vector; Spectr 23
pPCR4a cCF10 expression construct derived from prgQ region cloned into pDL278 45
V2L V3L change at position 2 of cCF10 24
T3S T3S change at position 3 of cCF10 24
L4V L3V change at position 4 of cCF10 24
L4I L3I change at position 4 of cCF10 24
F6Y F3Y change at position 6 of cCF10 24
V7I V3I change at position 7 of cCF10 24
pJRC2 pPCR4 construct altered to express cAM373 signal peptide and
pheromone from prgQ promoter
This study
pJRC3 pJRC2 construct altered to express cCF10 This study
pJRC4 pPCR4 construct altered to express native iCF10 peptide This study
pGEM-T-Easy Ampr lacZ cloning vector Promega
pGEM pJRC2 pGEM-T-Easy containing 250-bp PCR product used for cloning pJRC2 This study
pGEM pJRC3 pGEM-T-Easy containing 250-bp PCR product used for cloning pJRC3 This study
pDL276 Gram-positive cloning shuttle vector; Kanr 23
pMSP6043 prgN, -O, -P, -W, -Z, and -Y cloned into pDL276 26
pMSP6049 prgN, -O, -P, -W, and -Y cloned into pDL276 26
pMSP6043-1 prgN, -O, -P, -W, and -Z cloned into pDL276 12
pMSP6043-2 prgN, -O, -P, and -W cloned into pDL276 This study
pMSP3545 Nisin-inducible cloning vector 8
pMSP3545Y prgY cloned into pMSP3545 This study
pMSP3545Sb Spectr derivative of pMSP3545 12
pMSP3545S-1 Cloned E. faecalis pCF10 prgY 12
pMSP3545S-2 Cloned E. faecalis pPD1 traB 12
pB/Y1 Fusion of prgY after pPD1 traB base 726 This study
pB/Y2 Fusion of pPD1 traB after prgY base 723 This study
pB/Y3 Fusion of prgY after pPD1 traB base 234 This study
pB/Y4 Fusion of prgY after pPD1 traB base 375 This study
pB/Y5 Fusion of pPD1 traB after prgY base 960 This study
pB/Y6 Fusion of pPD1 traB after prgY base 1050 This study
pB/Y9 pPD1 traB fusion between bases 234 and 375 of prgY This study
pB/Y10 pPD1 traB fusion between bases 375 and 1098 of prgY This study
a Constructs expressing mutant cCF10 peptides V2L, T3S, L4V, L4I, F6Y, and V7I were made by oligonucleotide-directed random mutagenesis of the cCF10 coding
sequence of the pPCR4 construct, and their construction is described by Fixen et al. (24).
b Genes and chimeric gene fusions in pMSP3545S-1 and -2 and B/Y1-10 were cloned into NcoI and XbaI of pMSP3545S.
c Spectr, spectinomycin resistance; Ampr, ampicillin resistance; Kanr, kanamycin resistance.
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defined as the log2 of the number of wells that clumped in the presence of the
culture filtrate subtracted from the log2 of the number of wells that clumped in
the absence of the culture filtrate.
-Galactosidase assay. Strains were grown overnight in M9-YE medium and
then diluted 1:5 into fresh M9-YE medium and grown an additional 1 h before
addition of iCF10 or supernatant from a cCF10-expressing strain grown over-
night in THB. After induction the cultures were incubated for an additional 90
min. 	-Galactosidase assays were performed as described previously (15). The
results were averaged from technical duplicates and are shown as representative
experiments or as averaged results from two or more independent experiments
that were each done in duplicate (specified in the figure legends).
RESULTS
iCF10 is insufficient to neutralize endogenous cCF10 that is
reimported by PrgZ. PrgY and iCF10 are two distinct gene
products that control endogenously produced cCF10 activity.
In a donor strain harboring a prgY disrupted pCF10 derivative,
iCF10 cannot control self-induction of donor aggregation (9).
A more sensitive method to detect self-induction by cCF10 was
utilized to determine whether iCF10 could independently con-
trol some endogenous pheromone in the absence of PrgY. This
was done by using the reporter plasmid pBK2. pBK2 carries
the pCF10 regulatory genes encoding PrgX and iCF10 and also
has a prgQ::lacZ fusion that sensitively reports cCF10 induc-
tion (34). As observed previously for a strain harboring prgY-
disrupted pCF10 (14), a strain harboring pBK2 constitutively
expressed prgQ-dependent reporter gene activity due to self-
induction by endogenous cCF10 (Fig. 2, Vector, black bar).
Exogenously added iCF10 decreased this basal level of induc-
tion significantly (Fig. 2, Vector), indicating that iCF10 can
control self-cCF10 independent of PrgY. We also used this
system to address whether the pCF10-encoded surface-ex-
pressed pheromone-binding protein PrgZ affects donor cell
sensitivity to self-cCF10. PrgZ significantly increases pCF10
sensitivity to cCF10 (39); thus, we hypothesized that PrgZ
expression would also increase sensitivity to self-cCF10 even
when iCF10 is exogenously added. Indeed, PrgZ expression
increased pBK2 reporter activity 5-fold in the absence or
presence of 50 or 500 ng of iCF10/ml (Fig. 2, PrgZ). Because
PrgZ protein levels may be higher in this system (due to its
expression from a multicopy cloning vector) than in wild-type
donor cells, the PrgZ-dependent increase in cCF10 sensitivity
may not be as high as in cells carrying pCF10. However, these
results support that PrgZ expression increases donor sensitivity
to self-cCF10 and that iCF10 is insufficient to control self-
cCF10 that is reimported by PrgZ. iCF10. PrgY expression
reduced reporter activity levels nearly to zero even when PrgZ
was coexpressed (Fig. 2, PrgY and PrgYPrgZ). The addition
of the solvent dimethyl formamide used for dissolving iCF10
and cCF10 did not significantly affect induction levels (data not
shown). These results demonstrate that iCF10 functions inde-
pendent of PrgY but is not sufficient to control high levels of
PrgZ-dependent cCF10 activation. Therefore, both PrgY and
iCF10 are necessary for the control of endogenous pheromone
in the presence of PrgZ.
The membrane protease Eep is involved in both cCF10 and
iCF10 production. cCF10 is processed from the 22-amino-acid
signal sequence of the chromosomally encoded CcfA lipopro-
tein (3) (Fig. 1B). Eep was previously shown to be involved in
production of the pheromones cCF10, cPD1, cAD1, and the
inhibitor iAD1 but was not involved in processing of the pher-
omone cAM373 (1, 2). To test whether Eep is also involved in
processing iCF10, a strain was made with a disruption in eep
using markerless allelic exchange (see Materials and Meth-
ods). Plasmid pJRC4 was constructed that carries the PQ-
driven prgQ open reading frame (ORF) encoding iCF10 (Fig.
3), and this plasmid was moved into strain JRC110 to test for
iCF10 production in the absence of Eep. iCF10 production
from pJRC4 was undetectable in strain JRC110,compared to a
titer of 32 in the Eep strain JRC107 (Table 3). A similar
plasmid, pPCR4, encodes cCF10 within the 3 end of the prgQ
Orf (45), and pPCR4-produced cCF10 activity was similarly
much higher in the Eep strain than in the Eep strain (Table
3). These results show for the first time that Eep is involved in
iCF10 production from the prgQ Orf. Attempts to clone PQ
driven cCF10 and its native N-terminal peptide (the CcfA
signal sequence) were unsuccessful, possibly due to a toxic
effect of such a high level of cCF10 expression by this con-
struct; however, in the Eep strain JRC110 cCF10 activity
FIG. 2. iCF10 is insufficient to control endogenous pheromone in the absence of PrgY. Pheromone induction by endogenous pheromone was
measured in OG1RF(pBK2) strains coharboring a plasmid expressing PrgZPrgY (pMSP6043), PrgY (pMSP6049), PrgZ (pMSP6043-1), or a
vector control (pMSP6043-2). Cultures grown overnight in M9 medium were diluted 1:5, and 	-galactosidase levels were determined after 2.5 h
of growth. iCF10 was added at 0, 50, 500, or 5,000 ng/ml to overnight cultures and again to diluted cultures. The data shown are representative
of three independent experiments, each performed in duplicate.
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from chromosomally encoded CcfA was undetectable (data
not shown). Of note, JRC110(pPCR4) exhibited a low level of
cCF10 production (Table 3), suggesting that another protease
in this Eep-deficient strain may mediate processing of cCF10 at
a greatly reduced efficiency.
Eep functions posttranslationally through recognition of a
precursor peptide sequence N-terminal to the mature phero-
mone or inhibitor sequence. With the exception of Eep, S2P
proteases generally are involved in the cleavage and release of
membrane-bound transcription factors (50). Thus, it is for-
mally possible that Eep could regulate such a factor and
thereby control the activity of promoters for genes encoding
pheromones and inhibitors. To determine whether Eep could
act indirectly on pheromone production by cleavage of a tran-
scription factor regulating expression of the pheromone, we
made use of the prgQ promoter (PQ) driving pheromone ex-
pression in plasmid pPCR4. If this promoter was regulated by
Eep-mediated signaling, then any gene expressed from PQ
would show similar changes in expression in the eep knockout
strain. A previous study demonstrated that Eep is not involved
in the production of cAM373 (2); therefore, plasmid pJRC2
was constructed, which encodes the cAM373 pheromone and
signal sequence downstream of PQ (Fig. 3). Plasmid pJRC2
was moved into strains JRC107 and JRC110 to determine
whether Eep is involved in cAM373 production when it is
expressed from the PQ promoter. cAM373 production from
plasmid pJRC2 was the same for both the Eep and Eep
strains (Table 3), indicating that Eep acts posttranscriptionally
and supporting the notion that Eep functions as a protease that
directly processes pheromone/inhibitor precursors.
To elucidate the peptide sequence recognized by Eep, a
chimeric construct was made to determine whether the N or C
terminus of the peptide substrate is important for Eep process-
ing. Plasmid pJRC3 was derived from pJRC2, but the cAM373
pheromone sequence was changed to encode cCF10 (Fig. 3).
The production of cCF10 from pJRC3 was Eep independent
(Table 3), whereas cCF10 production from an iCF10-derived
N-terminal peptide was greatly enhanced by Eep (pPCR4,
Table 3). This demonstrates that the N-terminal sequence of
the signal peptide is important for recognition by Eep.
PrgY recognizes cCF10 peptide sequence regardless of se-
quence N-terminal to cCF10. Like Eep, PrgY specifically rec-
ognizes endogenously produced pheromone (12). The poten-
tial specificity determinants recognized by PrgY are currently
unknown. To elucidate whether PrgY targets the cCF10 hepta-
peptide or adjacent amino acids that are part of the precursor
peptide, the PQ-driven peptide expression constructs pPCR4
and pJRC3 (Fig. 3) were coexpressed with PrgY or a vector
control, and the PrgY ability to decrease pheromone activity in
each strain was measured. Because PQ-driven pheromone ac-
tivity is very high in cell culture supernatants (Table 3) the
effect of PrgY expression on this pheromone activity was dif-
ficult to measure using clumping of an OG1RF(pCF10) strain
as a biological assay. Therefore, a more sensitive and quanti-
tative assay was developed. We used a cCF10-inducible
	-galactosidase reporter construct p043lacZ (4) for measuring
pheromone activity in the cell culture supernatants (see Ma-
terials and Methods).
In strains harboring pPCR4 and pJRC3, cCF10 is processed
from a non-native peptide sequence. To determine whether
PrgY targets cCF10 produced from non-native signal se-
quences, we measured the cCF10 activity in strains coharbor-
ing pPCR4 or pJRC3 with pMSP3545Y (expressing PrgY) or
pMSP3545 (vector). PrgY reduced the activity of cCF10 pro-
duced by both pPCR4 and pJRC3 (Fig. 4A). It is unclear why
PrgY more efficiently reduced pPCR4-produced cCF10 than
pJRC3-produced cCF10. Possibly, PrgY targets the former
better than the latter. Alternatively, PrgY function could be






JRC107(pJRC4)  iCF10 iCF10 32
JRC110(pJRC4) – iCF10 iCF10 1
JRC107(pPCR4)  iCF10 cCF10 4,096
JRC110(pPCR4) – iCF10 cCF10 64
JRC107(pJRC2)  cAM373 cAM373 8,192
JRC110(pJRC2) – cAM373 cAM373 8,192
JRC107(pJRC3)  cAM373 cCF10 8,192
JRC110(pJRC3) – cAM373 cCF10 8,192
a Strain JRC107 is cCF10 and GelE/SprE deficient but Eep positive (); strain
JRC110 is derived from JRC107 but is Eep deficient (). See Materials and
Methods for details.
b The N terminus of the peptide is native to either the iCF10 or the cAM373
propheromone sequence and is designated as such (see Fig. 2 and 3). The C
terminus of the peptide is the active portion and is either cCF10, iCF10, or
cAM373, as designated (see Fig. 2 and 3).
c Supernatants (grown 6 h from a 10% overnight inoculum induced) were
diluted twofold, and cCF10 or cAM373 activity is reported as the inverse of
the largest dilution that was able to aggregate an OG1RF(pCF10) or
OG1RF(pAM373) indicator strain. The iCF10 activity is reported as the
extent of reduction of the ability to aggregate OG1RF(pCF10) relative to a
parallel 50-ng/ml cCF10 control (see Materials and Methods). The 50-ng/ml
control had a cCF10 titer of 512, and culture filtrates with iCF10 activity were
diluted 1:50 in THB prior to determination of the iCF10 activity. The relative
activities are representative of at least two independent experiments. A titer
of 1 indicates that no active pheromone or inhibitor was observed at the
dilutions examined.
FIG. 3. PQ-driven peptide expression constructs used in these stud-
ies. (A) Diagram of the peptide-coding portion of the plasmids. Tran-
scription of each peptide is driven by the prgQ promoter (PQ), shown
at the left. Within the 22- to 23-amino-acid peptide of each plasmid is
an N-terminal peptide sequence derived from the iCF10 or cAM373
preprocessed sequence (N-terminal peptide) and a pheromone or in-
hibitor at the C-terminal end (in gray). (B) N-terminal peptide and
pheromone/inhibitor that is encoded within each plasmid. For details
regarding the construction of these plasmids, see Materials and Meth-
ods.
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saturated in these strains due to very high cCF10 production.
In any case, these results support that PrgY targets the cCF10
heptapeptide and not the N-terminal amino acids of the cCF10
precursor. PrgY did not reduce cAM373 activity when it was
produced endogenously from its native signal sequence (Fig.
4B), whereas PrgY can decrease endogenous cCF10 activity by
50% (Fig. 4B) (12).
The fourth residue of the cCF10 peptide is important for
PrgY recognition. To further define the PrgY-targeted speci-
ficity determinants within the seven amino acids that comprise
cCF10, we made use of a library of functional cCF10 variants
(24). These variants were identified in a previous study using
random oligonucleotide-directed mutagenesis of plasmid
pPCR4 (24). The resulting peptide variants were screened for
reduced ability to induce expression of pCF10 conjugation
machinery [measured by clumping of OG1RF(pCF10)]. Al-
though 14 amino acid substitutions were originally identified in
the screen that influence biological activity of cCF10, only
peptide variants that retained relatively high biological activity
as inducing pheromones were tested for PrgY recognition to
ensure that PrgY-dependent reductions in activity would be
measurable. We tested cCF10 peptide variants with the muta-
tions V2L, T3S, L4V, L4I, F6Y, and V7I, representing changes
in most of the amino acids of cCF10 (amino acid substitutions
at positions 1 and 5 were not tested here due to their low
pheromone activity). Strains were made expressing each of
these peptide variants with PrgY or a vector control, and the
PrgY-dependent reduction of peptide activity was measured by
using a 	-galactosidase reporter assay to measure the phero-
mone activity in culture supernatants. The results demonstrate
that PrgY reduced the supernatant activity of each peptide
variant except one with an L4I substitution (Fig. 5). This L4I
FIG. 4. (A) PrgY reduces the activity of cCF10 processed from
both the iCF10 and the cAM373 signal peptides. Supernatant from
JRC107 or JRC110 (Eep) strains harboring pPCR4 or pJRC3 and
pMSP3545Y (expressing PrgY) or pMS3545 (vector) were used to
induce exponentially growing OG1RF(p043lacZ) strains, and the abil-
ity of supernatant cCF10 to induce LacZ expression of this strain was
measured by 	-galactosidase assay and expressed in Miller units. The
PrgY-dependent percent reduction of cCF10 activity (PrgY/Vector)
was averaged from three independent experiments (error bars repre-
sent the standard deviation of three independent experiments).
(B) PrgY does not decrease endogenous cAM373 activity. Cell culture
supernatants prepared as for Table 3 were diluted twofold, and the
pheromone activity is represented as the inverse of the largest dilution
able to aggregate an OG1RF(pCF10) or OG1RF(pAM373::pAD2)
indicator strain. The titers represent the results of two independent
experiments; the same results were seen for both assays.
FIG. 5. PrgY targets L4 of cCF10. Wild-type (WT) cCF10 peptide from pPCR4 or cCF10 variants were coexpressed with PrgY (pMSP3545Y)
or a vector control (pMSP3545). The peptide produced by each strain during overnight growth in THB was collected in the supernatant and used
to induce an exponentially growing responder strain OG1RF(p043lacZ) for 1.5 h, and the 	-galactosidase activity was subsequently determined.
Cell culture supernatants were added to the responder strain at a 1:100 dilution (for three cCF10 variants with low activity [V2L, L4V, and F6Y])
or at a 1:200 dilution (for all others). (A) Absolute values and (B) the PrgY-dependent percent reduction of cCF10 activity are shown. For both
panels A and B, the error range represents the standard deviation of two independent experiments. MU, Miller units.
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peptide variant had the same activity in supernatants of PrgY
and PrgY strains, suggesting that this sequence change abol-
ished targeting by PrgY. These results also support that PrgY
interacts with the cCF10 peptide.
Amino acids 125 to 241 of PrgY comprise a domain specific
for cCF10 interaction. Our previous genetic data indicate that
the functional domain for PrgY lies within a predicted extra-
cellular domain including the first 150 amino acids of the
317-residue polypeptide. We believe that the primary function
of the C-terminal segment (residues 250 to 317) is to anchor
the protein with the proper topology in the cell membrane.
Previous studies suggest that PrgY recognition of cCF10 is
specific (12); thus, we hypothesized that there is also a domain
in PrgY that mediates cCF10 specificity. Such findings would
further support the notion that there is a specific interaction
between PrgY and cCF10. To test this hypothesis, genetic
fusions were made between prgY and a homolog traB encoded
by plasmid pPD1; TraB controls its cognate pheromone cPD1
but does not efficiently control cCF10 (12). These chimeras
were used to characterize PrgY-encoded cCF10 specificity de-
terminants by testing their ability to reduce supernatant cCF10
activity. PrgY and TraB share high similarity (92% at the
amino acid level), supporting that chimeric fusions would re-
tain functional activity. In addition, PrgY has overlapping spec-
ificity for cPD1 and can reduce supernatant cPD1 activity to
comparable levels as TraB (12). Thus, the functional activity of
each chimera could be determined by testing their ability to
reduce supernatant cPD1 activity.
Chimeras were constructed from pPD1 traB and pCF10 prgY
genes by reciprocal exchange of the coding sequences using
overlap extension PCR. Eight chimeric traB/prgY genes were
generated and cloned into the multicopy vector pMSP3545S
(12) to yield the plasmids pB/Y1 to pB/Y6, pB/Y9, and pB/Y10
(Table 2). Because the GelE protease can degrade phero-
mones (51), chimeric proteins were expressed in the E. faecalis
GelE-deficient strain TX5128 (48) and tested for their ability
to reduce cCF10 or cPD1 activity in the supernatant compared
to wild-type PrgY or TraB or a vector control. As previously
seen (12), strains expressing PrgY or TraB had reduced cPD1
levels in cell culture supernatants, and PrgY expression simi-
larly reduced cCF10 levels (Fig. 6). TraB expression did not
affect cCF10 levels (Fig. 6). Previously, TraB partially reduced
cCF10 levels (12), but this partial phenotype was most likely
masked in the present experiments because cCF10 levels were
slightly different than previously observed. To determine
whether cCF10 specificity was retained in the N- or C-terminal
half of PrgY, we tested the chimeric plasmids pB/Y1 or pB/Y2
that each encoded PrgY fused to the N- or C-terminal half of
TraB, respectively. The chimeric protein B/Y2 reduced super-
natant cCF10 levels by 50% compared to the vector control,
whereas B/Y1 did not reduce cCF10 levels (Fig. 6A), suggest-
ing that B/Y2 retained specificity for cCF10 and that the
cCF10-specific domain is localized to the N terminus of PrgY.
To more precisely define the PrgY domain responsible for
cCF10 specificity, chimeric constructs were tested that encoded
smaller fragments of pPD1 TraB fused to PrgY. All of the
chimeric proteins except B/Y10 reduced supernatant cCF10
activity to a level similar to that of PrgY (Fig. 6A), demon-
strating that each of these chimeras retained PrgY-encoded
cCF10 specificity determinants. In contrast, B/Y10 did not
affect cCF10 levels, and B/Y10 has the TraB amino acid se-
quence internal to the N terminus of PrgY spanning amino
acids 125 to 241. These results indicate that a cCF10 specificity
domain may be localized to amino acids 125 to 241.
The functional activity and stability of each of the chimeric
proteins was determined by ensuring that the chimeras re-
tained the ability to reduce cPD1 activity and by Western blot
analysis (Fig. 6). These results support that the chimeras were
sufficiently stable to retain functional pheromone control ac-
tivity, although it is formally possible that cCF10 control could
be more sensitive to minor reductions in stability than pPD1
control. To test protein expression levels, a Western blot with
a polyclonal anti-PrgY antibody was used to detect chimeric
proteins in cell extracts (Fig. 6B). The chimeric proteins B/Y1
and B/Y10 were unable to reduce cCF10 activity but were
FIG. 6. Specific reduction of cCF10 activity is conferred by PrgY
amino acids 125 to 241. (A) cCF10 or cPD1 activity was measured in
supernatants of TX5128 strains harboring the indicated construct. Cell
culture supernatants (grown 6 h from a 10% overnight inoculum in-
duced with 25 ng of nisin/ml) were diluted twofold, and the pheromone
activity was determined in a clumping induction assay using
OG1RF(pCF10) or (pPD1) indicator strains. The PrgY-dependent
percent reduction of cCF10 activity averaged from two independent
experiments (the error represents the standard deviation of two inde-
pendent experiments; the cCF10 titer in the absence of PrgY, TraB, or
a chimeric protein was 16 in the first experiment and 32 in the second).
cPD1 was similarly assayed twice with the same results each time; the
cPD1 titer was 4 in the absence of either PrgY or TraB, and all of the
chimeras completely reduced all cPD1 activity. (B) The expression of
pPD1 TraB (P), PrgY (Y) and TraB/PrgY chimeras 1 to 6, 9, and 10
(labeled 1 to 6, 9, and 10) in whole-cell extracts was analyzed by
Western blotting with a polyclonal anti-PrgY antibody (8). TX5128 was
the strain background in these experiments. The arrow at 43 kDa
corresponds to the expected size of PrgY. All strains were treated with
25 ng of nisin/ml for 2.5 h prior to harvesting. An equivalent amount
of protein was loaded for each sample.
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detectable with a PrgY antibody at about the same level as
PrgY, supporting that their expression and stability is similar to
PrgY. These combined results indicate that PrgY amino acids
125 to 241 comprise a domain that is important for cCF10
specificity. It is noteworthy that when the amino acid sequence
identity and similarity of residues 180 to 240 of both proteins
are compared to that of the entire 250 residue extracellular
domain, the divergence between the two proteins is highest in
residues 180 to 240 (not shown), which would not be unex-
pected based on the functional studies of the chimeras.
PrgY function is independent of Eep. PrgY and Eep are both
transmembrane proteins that target the CcfA signal peptide that
encodes cCF10. Given this, it is possible that PrgY and Eep
interact in the membrane and that PrgY functions specifically
through Eep (e.g., by specifically inhibiting Eep-dependent cCF10
processing). To address this possibility, we tested whether PrgY
can reduce cCF10 activity in the Eep-deficient strain JRC110. In
JRC110 supernatants, cCF10 activity is low but detectable when it
is overexpressed from plasmid pPCR4 (presumably because pro-
cCF10 can be processed inefficiently by another protease) (Table
3). The cCF10 activity in this strain was very low, and PrgY
coexpression further reduced cCF10 activity in this strain by 67%
(Fig. 7), demonstrating PrgY functions in the absence of Eep. We
also the tested PrgY ability to reduce the activity of pJRC3-
produced cCF10, which is Eep independent (see Table 3). PrgY
reduced activity of pJRC3-produced cCF10 by 27%, supporting
that the function of PrgY is Eep independent (Fig. 7B). We have
not ruled out the possibility that Eep and PrgY interact or are
colocalized in the membrane (this could account for the more
effective control of cCF10 produced from the Eep-dependent
precursor), but these results indicate that such an interaction is
not necessary for PrgY function.
FIG. 7. PrgY reduces the activity of cCF10 in the Eep-deficient strain JRC110. (A) cCF10 activity produced by pPCR4 expressed with
pMSP3545Y (PrgY) or pMSP3545 (vector), as indicated, in strain JRC110 was measured by clumping assay as described in Table 3 and Materials
and Methods. (B) PrgY-dependent percent reduction of cCF10 activity for JRC110 strains harboring pPCR4 (cCF10 processed from the iCF10
leader) or pJRC3 (cCF10 processed from the cAM373 leader). For both panels A and B, the results are averaged from three independent
experiments done in duplicate (error bars represent the standard deviation of three independent experiments).
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DISCUSSION
In this work, we genetically characterized several of the
important steps that take place during cCF10 processing and
control in a pCF10-containing donor cell. Two proteins in-
volved in this process were the focus of the present study:
PrgY, a pCF10-encoded membrane protein involved in donor-
mediated control of self-produced cCF10, and Eep, a chromo-
some-encoded membrane metalloprotease involved in the pro-
duction of cCF10 and several related pheromones. The nature
and specificity of the association of each of these proteins with
cCF10 had not previously been addressed and, prior to the
initiation of these studies, the steps of cCF10 processing and
release were based primarily on sequence analysis (3).
Eep was previously shown to be involved in the production
of cAD1, cPD1, and cCF10 (2), as well as of the pAD1 inhib-
itor peptide iAD1 (1). The results presented here demonstrate
that Eep is also involved in production of iCF10 (Table 3).
Inhibitor peptides are expressed from plasmid-encoded signal
sequence-like peptides whose expression is controlled at the
transcriptional level. Eep is closely related to the S2P SpoIVFB
of Bacillus subtilis, which transcriptionally regulates genes in-
volved in sporulation through the proteolysis and release of a
membrane-bound  factor K (44). Prior to the present study,
it was unclear whether Eep regulated pheromone and inhibitor
production by posttranscriptional peptide processing or at the
transcriptional level by a mechanism similar to SpoIVFB. To
address whether Eep transcriptionally regulates iCF10, we
used the iCF10 prgQ promoter (PQ) to drive expression of the
Eep-independent peptide cAM373 (Fig. 3). Production of
cAM373 from the non-native promoter PQ was also Eep inde-
pendent (Table 3), indicating that Eep does not transcription-
ally regulate pheromone production. Instead, these results sug-
gest that Eep acts posttranscriptionally to process the
pheromone and inhibitor precursors as they pass through the
membrane.
The recognition site of the Eep proteases is not known, and
the mechanism of intramembrane cleavage by S2P proteases
such as Eep is poorly understood. These proteases often target
single-transmembrane substrates that have been preprocessed
by another protease (7). In the case of the pheromone precur-
sor substrates, preprocessing may occur by signal peptidase II
to release the signal peptide, which is most likely the substrate
recognized by Eep. Our findings support that Eep indeed rec-
ognizes the mature signal peptide; we demonstrated that Eep
releases pheromone or inhibitor from the signal-sequence-like
polypeptides used for these studies (Table 3). These polypep-
tides are not cleaved by signal peptidase II, indicating that Eep
acts downstream and independently of signal peptidase II dur-
ing proteolytic processing of the pheromones from their li-
poprotein precursors.
The genetic determinants required for Eep recognition were
also characterized. We found that Eep recognizes the N-ter-
minal (nonpheromone or inhibitor) portion of the signal-se-
quence-like precursor peptides (amino acids 1 to 16 of the
iCF10 precursor sequence) (Table 3). SpoIVFB requires the
N-terminal 117 amino acids of its substrate for RIP-mediated
cleavage (42). The region recognized by Eep is much smaller
and is more similar to that of the E. coli S2P protein RseP
(YaeL), which requires the N-terminal 28 amino acids of its
substrate pro-E for RIP-mediated processing (10, 31). It has
been proposed that the substrate requirements for RIP cleav-
age are based on a secondary or tertiary structure of the pep-
tide substrate in the membrane rather than the primary se-
quence (38). Indeed, primary sequence analysis of known Eep
targets did not reveal a common motif (data not shown). Pos-
sibly, the N terminus of the Eep-recognized polypeptides de-
termines the structure in the bacterial cell membrane and
therefore directs Eep targeting.
The finding that PrgY does not require Eep (Fig. 7) was
important for developing a model for PrgY function. Prior to
these studies, one possible model involved PrgY inhibition of
Eep-mediated peptide cleavage. Our results indicate that this
is not the case. Rather, the results reported here suggest that
PrgY interacts directly with the cCF10 peptide, perhaps after
Eep proteolysis and release from the membrane. A direct
interaction between PrgY and the cCF10 peptide was sup-
ported by the following genetic results from this work: (i) the
finding that PrgY recognizes the cCF10 peptide sequence itself
rather than the surrounding N-terminal signal sequence resi-
dues (Fig. 4); (ii) the identification of a residue (L4) in cCF10
that is required for PrgY function (Fig. 5, L4I); and (iii) iden-
tification of a cCF10-specific domain in PrgY (Fig. 6). Like
PrgX, PrgY possibly binds cCF10 in a pocket (47) that can
tolerate some amino acid substitutions in cCF10 (24). Substi-
tutions that were tolerated by PrgY include all of those tested
except L4I (Fig. 5). At position L4, two changes (L4I versus
L4V) resulted in very different phenotypes, supporting that
some changes in cCF10 may be more tolerated by PrgY than
others. More severe changes to the other cCF10 residues may
be less tolerated by PrgY, but these types of changes could not
be detected since they most likely caused the loss of cCF10
activity.
Previously, a conserved functional domain was mapped to
the N-terminal half of PrgY based on mutations that abolish
function (12). These mutations primarily localize to a con-
served region of the first 150 amino acids of PrgY. In the
present study, an additional domain was identified from amino
acids 125 to 241 that confers cCF10 specificity. The C terminus
of PrgY from amino acids 250 to 384 is a predicted transmem-
brane domain (http://www.enzim.hu/hmmtop/). These three
PrgY domains are illustrated in Fig. 8A. The predicted topol-
ogy of PrgY and a preliminary experimental analysis of topol-
ogy involving 	-galactosidase and alkaline phosphatase fusions
to PrgY both suggest that this N-terminal domain is on the
outside of the cell membrane, as shown in Fig. 8B. Such an
orientation of PrgY would support a model wherein PrgY
interacts with cCF10 after it is released from the cell mem-
brane. This type of interaction would require that PrgY is
precisely positioned in the cell membrane so that cCF10 is
trapped immediately upon release and before reimport by
PrgZ (Fig. 8B). Our results support that this type of position-
ing does not require a direct interaction with Eep because
PrgY function is Eep independent, although a direct interac-
tion between these proteins could increase the efficiency of
PrgY control. Possibly, both PrgY and Eep are directed to the
same site in the cell membrane, such as the ExPortal microdo-
main identified in Streptococcus pyogenes wherein Sec-depen-
dent export of several characterized proteins is directed (43).
Our results provide the first genetic evidence for substrate
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recognition by Eep, as well as important insight into the mech-
anism of PrgY in endogenous pheromone control. Ongoing
experiments are aimed at biochemically characterizing cCF10
inactivation by PrgY and confirming a direct interaction be-
tween PrgY and cCF10. PrgY is representative of a novel
family of proteins with a potentially uncharacterized enzymatic
function, thus understanding the biology of this intriguing pro-
tein may be relevant to the entire protein family. Questions
about the S2P family member Eep also remain, including its
substrate target site, the mechanism for peptide release from
the membrane, and the motifs that are involved in S2P-medi-
ated substrate recognition.
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